共 12 条
[9]
Different Response to Rituximab in Tumor Necrosis Factor Blocker-Naive Patients With Active Ankylosing Spondylitis and in Patients in Whom Tumor Necrosis Factor Blockers Have Failed A Twenty-Four-Week Clinical Trial
[J].
ARTHRITIS AND RHEUMATISM,
2010, 62 (05)
:1290-1297